Award
Delivery Order #SPE2DR26F23GN
Delivery Order for Xeljanz XR Tablets under AmerisourceBergen IDV Contract
Buyer
Defense Logistics Agency
Award Amount
$3,877.13
Ceiling
$3,877.13
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26F23GN
NAICS
424210
This delivery order contract was awarded to AmerisourceBergen Drug Corp, a global leader in pharmaceutical distribution, for the procurement of Xeljanz XR 11 mg tablets. The contract serves as a short-term acquisition under a larger indefinite delivery vehicle (IDV) previously established with AmerisourceBergen, which supports pharmaceutical supply requirements for federal health services. The current order entails supplying a specified quantity of the medication, contributing to the continued availability of critical treatments for public health initiatives. Awarded through the existing IDV contract as a follow-on delivery order, this contract involved a competitive framework previously established by the parent agreement. The contract's execution is scheduled for a brief period in early 2026, underscoring its role in meeting immediate pharmaceutical needs within government healthcare programs.
Description
4571004211!XELJANZ XR 11 MG TABLET UU 30S